KRAS and non-small cell lung carcinoma: found that AKT1 is a key metastasis regulator in NSCLC cells, and in vitro inhibition of AKT1 can promote invasion and metastasis of NSCLC cells with K-RAS or EGFR mutations (Rao et al., 2017).